BIOA

Bioage Labs Stock Analysis

AI Rating

Great
  • Quality3/10
  • Growth 9/10
  • Momentum 9/10
Bioage Labs sales and earnings growth
BIOA Growth
Great
  • Revenue Y/Y 0.00%
  • EPS Y/Y 138.96%
  • FCF Y/Y -7.10%
Bioage Labs gross and profit margin trends
BIOA Profitability
Neutral
  • Gross margin 100.00%
  • EPS margin -1280.90%
  • ROIC -137.60%
Bioage Labs net debt vs free cash flow
BIOA Risk
Great
  • Debt / Equity 0.0
  • Debt / FCF 0.0
  • Interest coverage -81.0

Bioage Labs stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗